This methodology identifies when to collect data to improve breast cancer risk predictions, enhancing clinical decision making.
Our results demonstrate that, in some cases, there is considerable probability of reclassification after collecting missing data. Methodology presented here can identify situations where it would be most beneficial to collect additional information, to enable better informed clinical decision making.
No takes yet. Share an insight, caveat, or question.
White et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: